Melanoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
The National Comprehensive Cancer Network (NCCN) recommends the following:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | Measures for secondary prevention for melanoma depends on the stage of melanoma at diagnosis. To view the stages of melanoma, click [[Melanoma staging|'''here''']]. | ||
*The National Comprehensive Cancer Network (NCCN) recommends the following:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | |||
===Stage 0 at Diagnosis=== | ===Stage 0 at Diagnosis=== | ||
Revision as of 02:51, 22 August 2015
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Melanoma secondary prevention |
|
Risk calculators and risk factors for Melanoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
The choice of work-up for secondary prevention of melanoma is based on the stage of melanoma at diagnosis. Secondary prevention includes routine dermatologic evaluations, monthly self-exams, and chest and brain imaging.
Secondary Prevention
Measures for secondary prevention for melanoma depends on the stage of melanoma at diagnosis. To view the stages of melanoma, click here.
- The National Comprehensive Cancer Network (NCCN) recommends the following:[1]
Stage 0 at Diagnosis
- Annual dermatologic evaluation for life
- Patient education regarding monthly self-skin exams
Stage IA at Diagnosis
- Dermatologic evaluation every 3-12 months for the first 5 years following diagnosis then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
Stage IB-IIA at Diagnosis
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
- Chest x-ray and measurement of CBC and LDH every 6-12 months may be considered (optional)
Stage IIB-IV at Diagnosis
- Imaging screening by annual brain MRI AND either chest X-ray, positron emission tomography (PET), or CT scan (preferred) every 3-12 months for the first 5 years.
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Measurement of CBC and LDH every 6-12 months may be considered (optional)
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
References
- ↑ Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.